Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Alcidion Group Limited ( (AU:ALC) ).
Alcidion Group Limited announced its participation in an investor roadshow in Sydney, aiming to engage with investors and present its growth strategy following the FY25 results. This initiative reflects Alcidion’s commitment to expanding its market presence and underscores its strategic focus on leveraging technology to transform healthcare delivery.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare industry, providing innovative technology solutions designed to enhance the efficiency and quality of patient care. Their flagship product, Miya Precision, offers a suite of software products and technical services that improve clinical decision-making and operational communication in healthcare settings globally.
Average Trading Volume: 1,012,614
Technical Sentiment Signal: Hold
Current Market Cap: A$122.2M
Find detailed analytics on ALC stock on TipRanks’ Stock Analysis page.